Acute exacerbations in the INPULSIS trials of nintedanib in idiopathic pulmonary fibrosis

The European Respiratory Journal
Harold R CollardRoland M du Bois

Abstract

Time to first investigator-reported acute exacerbation was a key secondary end-point in the INPULSIS trials of nintedanib in patients with idiopathic pulmonary fibrosis (IPF).We used the INPULSIS trial data to investigate risk factors for acute exacerbation of IPF and to explore the impact of nintedanib on risk and outcome of investigator-reported and adjudicated confirmed/suspected acute exacerbations. Mortality following these events and events adjudicated as not acute exacerbations was analysed using the log rank test.Risk of acute exacerbations was most strongly associated with the following variables: baseline forced vital capacity (higher risk with lower value), baseline supplemental oxygen (higher risk with use), baseline antacid medication (higher risk with use), treatment (higher risk with placebo), and for confirmed/suspected acute exacerbations, cigarette smoking. Mortality was similar following investigator-reported and adjudicated confirmed/suspected acute exacerbations. Nintedanib had no significant effect on risk of mortality post-exacerbation.Investigator-reported acute exacerbations of IPF are associated with similar risk factors and outcomes as adjudicated confirmed/suspected acute exacerbations.

References

Jun 23, 2007·American Journal of Respiratory and Critical Care Medicine·Harold R CollardUNKNOWN Idiopathic Pulmonary Fibrosis Clinical Research Network Investigators
May 3, 2008·American Journal of Respiratory and Critical Care Medicine·Masanori AkiraMitsunori Sakatani
Dec 10, 2009·The European Respiratory Journal·H TaniguchiUNKNOWN Pirfenidone Clinical Study Group in Japan
Jul 3, 2010·The European Respiratory Journal·J W SongD S Kim
Aug 6, 2010·Internal Medicine·Toshiki YokoyamaKeishi Kubo
Oct 12, 2010·American Journal of Respiratory and Critical Care Medicine·Brett LeyTalmadge E King
Apr 8, 2011·American Journal of Respiratory and Critical Care Medicine·Ganesh RaghuUNKNOWN ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis
Oct 14, 2011·The New England Journal of Medicine·Luca RicheldiRoland M du Bois
Dec 21, 2011·The European Respiratory Journal·J S LeeH R Collard
May 9, 2012·American Journal of Respiratory and Critical Care Medicine·Imre NothUNKNOWN Idiopathic Pulmonary Fibrosis Clinical Research Network (IPFnet)
Jul 16, 2013·Respiratory Research·Harold R CollardUNKNOWN IPFnet investigators
Nov 2, 2013·The European Respiratory Journal·Kerri A JohannsonHarold R Collard
May 20, 2014·Respiratory Medicine·Shinichiro OhshimoUlrich Costabel
May 20, 2014·The New England Journal of Medicine·Luca RicheldiUNKNOWN INPULSIS Trial Investigators
Aug 28, 2014·American Journal of Respiratory and Critical Care Medicine·Motoki NatsuizakaHiroki Takahashi
Mar 7, 2015·The European Respiratory Journal·Lutz WollinMartin Kolb
Sep 24, 2015·American Journal of Respiratory and Critical Care Medicine·Ulrich CostabelArata Azuma
Jun 15, 2016·American Journal of Respiratory and Critical Care Medicine·Harold R CollardFernando J Martinez

❮ Previous
Next ❯

Citations

Feb 23, 2018·Respirology : Official Journal of the Asian Pacific Society of Respirology·Amanda J PiperVasileios Kouranos
Aug 8, 2018·Journal of Clinical Medicine·Shaney L BarrattNazia Chaudhuri
Feb 26, 2019·Respirology : Official Journal of the Asian Pacific Society of Respirology·Hironao HozumiTakafumi Suda
Dec 24, 2018·European Respiratory Review : an Official Journal of the European Respiratory Society·Martin KolbShane Shapera
Jun 28, 2018·The European Respiratory Journal·Kevin R FlahertyMarlies Wijsenbeek
May 21, 2017·The European Respiratory Journal·Nathan HamblyMartin Kolb
Mar 2, 2018·PharmacoEconomics·Alex DiamantopoulosToby M Maher
Oct 28, 2017·The European Respiratory Journal·Ganesh Raghu
Feb 14, 2018·The European Respiratory Journal·Philippe BonniaudCarmen Garrido
Jul 10, 2019·The Annals of Pharmacotherapy·Roy Pleasants, Robert M Tighe
Jul 23, 2019·Respirology : Official Journal of the Asian Pacific Society of Respirology·Jin Woo SongBruno Crestani
Sep 19, 2019·Jornal brasileiro de pneumologia : publicaça̋o oficial da Sociedade Brasileira de Pneumologia e Tisilogia·Carlos Alberto de Castro PereiraMarcelo Fouad Rabahi
Oct 1, 2019·Expert Review of Respiratory Medicine·Amornpun WongkarnjanaMartin Rj Kolb
Jan 11, 2020·CPT: Pharmacometrics & Systems Pharmacology·Fei TangJulia Korell
Jan 30, 2020·Expert Review of Respiratory Medicine·Davide BiondiniPaolo Spagnolo
Jun 6, 2017·Current Opinion in Pulmonary Medicine·Paolo Spagnolo, Wim Wuyts
Feb 16, 2020·The European Respiratory Journal·Michael KreuterElisabeth Bendstrup
Aug 20, 2019·Respirology : Official Journal of the Asian Pacific Society of Respirology·Atsushi SuzukiYoshinori Hasegawa
Sep 8, 2019·Respiratory Research·Toby M Maher, Mary E Strek
Jul 18, 2018·Frontiers in Medicine·Paolo SpagnoloFrancesco Bonella
Sep 5, 2018·Respiratory Research·Ulrich CostabelGanesh Raghu
May 3, 2019·ERJ Open Research·Christopher J RyersonVenerino Poletti
May 17, 2019·Respirology : Official Journal of the Asian Pacific Society of Respirology·Elisabetta A Renzoni, Athol U Wells
Jan 10, 2020·BMC Pulmonary Medicine·Luca RicheldiGanesh Raghu
Sep 25, 2020·Respirology : Official Journal of the Asian Pacific Society of Respirology·Yuzo SuzukiTakafumi Suda
Oct 4, 2019·European Respiratory Review : an Official Journal of the European Respiratory Society·Bridget F Collins, Ganesh Raghu
Jul 26, 2018·Medical Sciences : Open Access Journal·Paloma Millan-BilliDiego Castillo
Mar 20, 2019·Medicina·Tomoo Kishaba
Dec 13, 2019·Multidisciplinary Respiratory Medicine·Caitlin QuinnStephenie T Manns
Jan 8, 2020·Respiratory Research·Claudia ValenzuelaMichael Kreuter
May 31, 2019·Respiratory Research·Laurie SnyderUNKNOWN IPF-PRO™ Registry investigators
Dec 15, 2020·Current Pulmonology Reports·Tejaswini Kulkarni, Steven R Duncan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved